These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 19128756)

  • 1. [Valproic acid induced-idiosyncratic hepatotoxicity].
    Mata Zubillaga D; Prieto Espuñes S; Ferrero de la Mano L; Herrero Mendoza B
    An Pediatr (Barc); 2008 Nov; 69(5):492-3. PubMed ID: 19128756
    [No Abstract]   [Full Text] [Related]  

  • 2. Valproic acid administration for hepatic fibrosis: a balance between antifibrotic efficacy and hepatotoxicity.
    Ikura Y; Iwasa Y; Ueda M
    Hepatology; 2010 Jun; 51(6):2227-8; author reply 2228. PubMed ID: 20513011
    [No Abstract]   [Full Text] [Related]  

  • 3. Hepatotoxicity and valproate therapy.
    Betrosian A; Frantzeskaki F
    Intern Med J; 2006 Nov; 36(11):752-4. PubMed ID: 17040368
    [No Abstract]   [Full Text] [Related]  

  • 4. [Severe liver damage following administration of valproic acid (Depakine)].
    Coeckelberghs M; van Caillie-Bertrand M; Bultinck J; Clara R
    Ned Tijdschr Geneeskd; 1980 Aug; 124(34):1428-31. PubMed ID: 6774268
    [No Abstract]   [Full Text] [Related]  

  • 5. Valproic-acid-induced thrombocytopenia and hepatotoxicity: discontinuation of treatment?
    Lackmann GM
    Pharmacology; 2004 Feb; 70(2):57-8. PubMed ID: 14685007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thinking beyond the obvious: hepatotoxicity secondary to idiosyncratic depakote toxicity.
    Chaudrey KH; Naser TB; Steinberg A; Avashia KD; Nouri-Kolouri M; Asadi S; Irshad Khan SI; Ihsan M
    Am J Ther; 2012 Nov; 19(6):403-6. PubMed ID: 21248613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Valproic-acid-associated pancreatitis and hepatic toxicity in children with endstage renal disease.
    Levin TL; Berdon WE; Seigle RR; Nash MA
    Pediatr Radiol; 1997 Feb; 27(2):192-3. PubMed ID: 9028861
    [No Abstract]   [Full Text] [Related]  

  • 8. [Valproic acid-induced idiosyncratic liver injury in 4 cases].
    Xiong H; Liu CT; Zhang YH; Bao XH; Jiang YW; Zhao H; Wu XP; Qin J
    Zhonghua Er Ke Za Zhi; 2012 Dec; 50(12):890-4. PubMed ID: 23324142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Valproic acid-induced DRESS syndrome with acute liver failure.
    van Zoelen MA; de Graaf M; van Dijk MR; Bogte A; van Erpecum KJ; Rockmann H; Maarschalk-Ellerbroek LJ
    Neth J Med; 2012 Apr; 70(3):155. PubMed ID: 22516584
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hepatitis due to antiepileptic agents].
    Davion T; Capron-Chivrac D; Andrejak M; Capron JP
    Gastroenterol Clin Biol; 1985 Feb; 9(2):117-26. PubMed ID: 3920108
    [No Abstract]   [Full Text] [Related]  

  • 11. Evidence for a potential protective effect of carnitine-pantothenic acid co-treatment on valproic acid-induced hepatotoxicity.
    Felker D; Lynn A; Wang S; Johnson DE
    Expert Rev Clin Pharmacol; 2014 Mar; 7(2):211-8. PubMed ID: 24450420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corticosteroid-Flared Hepatotoxicity Reversed With l -Carnitine Therapy in a Patient Treated With Long-Term Valproic Acid.
    Goren BI; Selvi E; Bektas B; Arslan F
    Am J Ther; 2022 Nov-Dec 01; 29(6):e774-e776. PubMed ID: 32496438
    [No Abstract]   [Full Text] [Related]  

  • 13. Cooccurrence of Two Different Genetic Diseases: A Case of Valproic Acid Hepatotoxicity in Nicolaides-Baraitser Syndrome (SMARCA2 Mutation)-Due to a POLG1-Related Effect?
    Hofmeister B; von Stülpnagel C; Berweck S; Abicht A; Kluger G; Weber P
    Neuropediatrics; 2020 Feb; 51(1):49-52. PubMed ID: 31541998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of L-carnitine treatment for valproate-induced hepatotoxicity.
    DeVivo DC
    Neurology; 2002 Feb; 58(3):507-8. PubMed ID: 11839873
    [No Abstract]   [Full Text] [Related]  

  • 15. Valproic acid-induced hepatotoxicity in Alpers syndrome is associated with mitochondrial permeability transition pore opening-dependent apoptotic sensitivity in an induced pluripotent stem cell model.
    Li S; Guo J; Ying Z; Chen S; Yang L; Chen K; Long Q; Qin D; Pei D; Liu X
    Hepatology; 2015 May; 61(5):1730-9. PubMed ID: 25605636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sodium valproate and hepatotoxicity in epileptics.
    Beran RG; Rischbieth RH
    Med J Aust; 1979 Dec; 2(11):603-4. PubMed ID: 119151
    [No Abstract]   [Full Text] [Related]  

  • 17. [Pathogenetic basis of pharmaceutical hepatitis induced by depakine in children].
    Podymova SD; Sadovnikova IV
    Eksp Klin Gastroenterol; 2009; (8):30-5. PubMed ID: 20469676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Valproic acid-induced hepatopathy: nine new fatalities in Germany from 1994 to 2003.
    Koenig SA; Buesing D; Longin E; Oehring R; Häussermann P; Kluger G; Lindmayer F; Hanusch R; Degen I; Kuhn H; Samii K; Jungck A; Brückner R; Seitz R; Boxtermann W; Weber Y; Knapp R; Richard HH; Weidner B; Kasper JM; Haensch CA; Fitzek S; Hartmann M; Borusiak P; Müller-Deile A; Degenhardt V; Korenke GC; Hoppen T; Specht U; Gerstner T
    Epilepsia; 2006 Dec; 47(12):2027-31. PubMed ID: 17201699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Remission of West syndrome associated with valproate hepatotoxicity.
    Go T
    Brain Dev; 2002 Jun; 24(4):257-9. PubMed ID: 12015170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Valproic acid related idiosyncratic drug induced hepatotoxicity in a glioblastoma patient treated with temozolomide.
    Neyns B; Hoorens A; Stupp R
    Acta Neurol Belg; 2008 Dec; 108(4):131-4. PubMed ID: 19239041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.